Everotas 5 Mg Tablet
What is Everotas 5 Mg
Everotas 5 mg Tablet is an antineoplastic medication with Everolimus as its active ingredient. It belongs to the class of mTOR (mammalian target of rapamycin) inhibitors, which play a crucial role in regulating cell growth and proliferation.
This medication is primarily used to treat various types of cancer, including advanced breast cancer, renal cell carcinoma, and pancreatic neuroendocrine tumors. Additionally, Everotas effectively prevents organ rejection in transplant patients by suppressing the immune response.
Everotas slows down the growth of cancer cells and can reduce tumor size, improving overall patient outcomes. This medication is manufactured and marketed by Intas Pharmaceuticals Ltd.
What are the benefits of using Everotas 5 Mg
Everotas 5 mg Tablet, containing Everolimus, offers several significant benefits, primarily in cancer treatment and organ transplantation. One of its primary uses is in managing various types of cancer, including advanced breast cancer, pancreatic neuroendocrine tumors, Renal cell Carcinoma, and Subependymal giant cell Astrocytoma. By killing the mTOR pathway, Everotas effectively slows down the growth and kills the cancer cells, thereby reducing tumor size and improving patient outcomes.
In addition to its anti-cancer properties, Everotas is also used to prevent organ rejection in transplant patients. It works by suppressing the immune response, which is crucial for maintaining the health of transplanted organs. This immunosuppressive effect helps ensure the body does not attack the new organ.
Overall, Everotas 5 mg Tablet is a valuable therapeutic option for patients with specific cancers and those undergoing organ transplantation. Its ability to target cancer growth while providing Immunosuppression makes it an essential component of modern oncological and transplant medicine.
How to take Everotas 5 Mg
Everotas 5 mg Tablet is prescription-based and should be taken as per a healthcare professional's instructions.
The general guidelines for taking this medication are listed below:
- Take Everotas 5 mg Tablet as prescribed by your doctor.
- Swallow a whole tablet with a glass of water without crushing, breaking, or chewing it.
- Generally taken once daily during bedtime after food.
- Do not take more than once in 24 hours.
- Everotas 5 mg can be taken with or without food, but for optimal effectiveness, it is essential to take it consistently at the same time each day.
Strengths and substitutes
Available strengths of Everotas 5 Mg Tablet:
$562.50 /10 tablets | |
$113.80 /10 tablets |
What are the side effects of Everotas 5 Mg
Like any medication, Everotas 5 Mg may cause some side effects. Most side effects are temporary and will subside as your body adjusts.
Common side effects of using Everotas 5 Mg Tablet are as follows:
- Weakness
- Fever
- Diarrhea
- Nausea
- Headache and Joint pain
- Anemia (low red blood cell count)
- High blood pressure
However, consult a healthcare professional if the side effects persist or worsen.
Safety advice
Liver disease
Everotas 5 Tablet has not been shown to have adverse effects in patients with liver conditions, so it is safe for use. Seeking medical advice from professionals is advised.
Kidney impairment
People with kidney problems can use these tablets, as they have no known effects on kidney function. However, it is recommended that they seek medical advice from professionals.
Pregnant and breastfeeding women
Limited data on its safety during pregnancy exist. However, it is recommended that this medication not be used during pregnancy. It is also not recommended to use this medicine for breastfeeding women without consulting a medic due to adverse effects.
Avoid
Avoid consuming alcohol with Everotas tablet, as it might impact the effectiveness of the medicine.
FAQs
Is Everotas 5mg Tablet a chemotherapy?
Yes, Everotas 5 mg Tablet is considered a chemotherapy medication. It contains Everolimus, an mTOR inhibitor used to treat various cancers, including breast, pancreatic, lung, and kidney. Additionally, it helps prevent organ rejection in transplant patients by suppressing the immune response.
How long can you take Everotas 5 mg Tablet?
There is no specific duration for taking Everotas 5 mg Tablet. Treatment is generally continued until clinical benefits are observed or unacceptable toxicity occurs. It is essential to follow your doctor's recommendations regarding the duration of therapy based on individual response and tolerance to the medication.
Is any monitoring required while taking Everotas 5mg Tablet?
Yes, regular monitoring is required while taking Everotas 5 mg Tablet. To prevent complications, your doctor will recommend periodic blood tests to check white blood cell counts, platelets, blood sugar levels, and kidney function. It is essential due to the medication's potential side effects, including immunosuppression and impact on liver and kidney function.
What is the composition of Everotas 5 mg Tablet?
The composition of Everotas 5 mg Tablet includes Everolimus as its active ingredient, with a strength of 5 mg per tablet. Everolimus is an mTOR inhibitor used primarily for preventing organ rejection in transplant patients and treating various cancers, including breast, kidney, and pancreatic cancer.
Is Everotas 5 mg Tablet cytotoxic?
Yes, Everotas 5 mg Tablet is considered cytotoxic. It contains Everolimus, an mTOR inhibitor that exerts cytotoxic effects against various human cancer cells, including those from breast, stomach, prostate, and renal cell carcinoma. This action helps to inhibit cancer cells and induce cell death, making it effective in cancer treatment.